БРИЛІНТА
Active Ingredient: Ticagrelor
Product Overview
About БРИЛІНТА
БРИЛІНТА is a prescription medication containing the active ingredient Ticagrelor, a potent antiplatelet agent used to prevent blood clots in patients with acute coronary syndrome (ACS) or myocardial infarction (MI). It works by inhibiting the P2Y12 receptor on platelet surfaces, thereby reducing platelet aggregation and the risk of thrombotic events.
Key Benefits & Uses
- Prevention of blood clots in patients with acute coronary syndrome (ACS)
- Reduction of the risk of myocardial infarction (MI) in patients with ACS
- Management of acute coronary syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI)
Active Ingredient & Action
Ticagrelor, the active ingredient in БРИЛІНТА, is a reversible P2Y12 receptor antagonist that selectively inhibits platelet activation and aggregation. By blocking the P2Y12 receptor, Ticagrelor prevents the activation of platelets, thereby reducing the risk of thrombotic events and improving patient outcomes in ACS and MI.
Important Notes
БРИЛІНТА should only be used under the guidance of a healthcare professional. Patients with a history of bleeding disorders, severe liver or kidney disease, or those taking other medications that may increase the risk of bleeding should be closely monitored. Regular blood tests may be required to monitor platelet function and adjust treatment as necessary.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
